Barts and the London School of Medicine and Dentistry
10
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
10.0%
1 terminated/withdrawn out of 10 trials
87.5%
+1.0% vs industry average
20%
2 trials in Phase 3/4
43%
3 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer Progression
Role: collaborator
The BEET-BP Trial - Investigating the Effect of Dietary Nitrates on Hypertension in Pregnancy
Role: collaborator
Optimal Strategy for the Management of ASCUS Cytology in Health Care Services of Medellin, Colombia
Role: collaborator
Prevention of Metabolic Complications of Glucocorticoid Excess
Role: collaborator
A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis
Role: collaborator
Functional Genomic Influences on Disease Progression and Outcome in Sepsis
Role: collaborator
Gender Differences in the Development, Treatment and Prognosis of Coronary Disease: A CALIBER Study
Role: collaborator
Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney Cancer
Role: lead
Self-Sampling in Women Who Do Not Undergo Routine Cervical Screening
Role: lead
Diindolylmethane in Treating Patients With Abnormal Cervical Cells
Role: lead
All 10 trials loaded